Pharmaceutical

Accord gears up to commercialise Hipra’s Covid-19 vaccine in the UK

Hipra’s Bimervax targets the alpha and beta viral variants, but the EMA recently said it seeks vaccines designed against XBB 1.5 Omicron.

Aug 4, 2023 - 20:00
Accord gears up to commercialise Hipra’s Covid-19 vaccine in the UK
Hipra’s Bimervax targets the alpha and beta viral variants, but the EMA recently said it seeks vaccines designed against XBB 1.5 Omicron.
Read the original article

Tags:

Previous Article

Evox Therapeutics teams with New York medical school to co-develop AAV vectors

Next Article

Cellectis to focus on CAR-T cell therapies in 2023

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: The Q2 health tech tracker: 13 key industry events and milestones to watch

STAT+: The Q2 health tech tracker: 13 key industry even...

Apr 5, 2023

His book on the opioid crisis flopped in 2003. It now has a new life on Netflix

His book on the opioid crisis flopped in 2003. It now h...

Jul 28, 2023

Senators push IRS to launch nonprofit hospital probe

Senators push IRS to launch nonprofit hospital probe

Aug 9, 2023